Epiminder Limited (ASX:EPI)
0.3200
0.00 (0.00%)
At close: Aug 7, 2026
Epiminder Market Cap
Epiminder has a market cap or net worth of 69.23 million as of August 7, 2026.
Market Cap
69.23M
Enterprise Value
-20.26M
Revenue
648.18K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.32
ChartMarket Cap Chart
Since December 1, 2025, Epiminder's market cap has decreased from 283.42M to 69.23M, a decrease of -75.57%. That is a compound annual growth rate of -87.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 69.23M | -68.63% |
| Dec 31, 2025 | 220.68M | -22.14% |
| Dec 1, 2025 | 283.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| EMVision Medical Devices | 141.76M |
| Lumos Diagnostics Holdings | 122.77M |
| SomnoMed | 92.01M |
| Cyclopharm | 68.71M |
| Compumedics | 46.94M |
| Cleo Diagnostics | 45.93M |
| Nova Eye Medical | 41.30M |
| HeraMED | 39.35M |